Invion Limited

ASX (AUD): Invion Limited (IVX)

Last Price

0.004

Today's Change

+0.001 (33.33%)

Day's Change

0.003 - 0.004

Trading Volume

3,200,201

Overview

Market Cap

20 Million

Shares Outstanding

5 Billion

Avg Volume

3,758,567

Avg Price (50 Days)

0.00

Avg Price (200 Days)

0.00

PE Ratio

0.00

EPS

0.00

Earnings Announcement

30-Aug-2024

Previous Close

0.00

Open

0.00

Day's Range

0.003 - 0.004

Year Range

0.002 - 0.008

Trading Volume

3,200,201

Price Change Highlight

1 Day Change

33.33%

5 Day Change

0.00%

1 Month Change

33.33%

3 Month Change

0.00%

6 Month Change

-20.00%

Ytd Change

-20.00%

1 Year Change

-20.00%

3 Year Change

-71.43%

5 Year Change

-73.33%

10 Year Change

-93.34%

Max Change

-98.68%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment